Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1991 1
1997 1
1998 2
1999 1
2004 1
2006 1
2008 1
2009 1
2012 2
2014 1
2015 4
2016 1
2017 2
2018 3
2019 3
2020 1
2021 6
2022 9
2023 14
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators. Choueiri TK, et al. N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25. N Engl J Med. 2015. PMID: 26406150 Free PMC article. Clinical Trial.
Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.
Mahlokozera T, Patel B, Chen H, Desouza P, Qu X, Mao DD, Hafez D, Yang W, Taiwo R, Paturu M, Salehi A, Gujar AD, Dunn GP, Mosammaparast N, Petti AA, Yano H, Kim AH. Mahlokozera T, et al. Among authors: desouza p. Nat Commun. 2021 Nov 3;12(1):6321. doi: 10.1038/s41467-021-26653-6. Nat Commun. 2021. PMID: 34732716 Free PMC article.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Long, Noncoding RNA Dysregulation in Glioblastoma.
DeSouza PA, Qu X, Chen H, Patel B, Maher CA, Kim AH. DeSouza PA, et al. Cancers (Basel). 2021 Mar 31;13(7):1604. doi: 10.3390/cancers13071604. Cancers (Basel). 2021. PMID: 33807183 Free PMC article. Review.
Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells.
Jang HJ, Shah NM, Maeng JH, Liang Y, Basri NL, Ge J, Qu X, Mahlokozera T, Tzeng SC, Williams RB, Moore MJ, Annamalai D, Chen JY, Lee HJ, DeSouza PA, Li D, Xing X, Kim AH, Wang T. Jang HJ, et al. Among authors: desouza pa. Nat Genet. 2024 Sep;56(9):1903-1913. doi: 10.1038/s41588-024-01880-x. Epub 2024 Sep 2. Nat Genet. 2024. PMID: 39223316
The neighborhood built environment and COVID-19 hospitalizations.
Rigolon A, Németh J, Anderson-Gregson B, Miller AR, deSouza P, Montague B, Hussain C, Erlandson KM, Rowan SE. Rigolon A, et al. Among authors: desouza p. PLoS One. 2023 Jun 14;18(6):e0286119. doi: 10.1371/journal.pone.0286119. eCollection 2023. PLoS One. 2023. PMID: 37314984 Free PMC article.
An environmental justice analysis of air pollution in India.
deSouza PN, Chaudhary E, Dey S, Ko S, Németh J, Guttikunda S, Chowdhury S, Kinney P, Subramanian SV, Bell ML, Kim R. deSouza PN, et al. Sci Rep. 2023 Oct 4;13(1):16690. doi: 10.1038/s41598-023-43628-3. Sci Rep. 2023. PMID: 37794063 Free PMC article.
Modeling glioblastoma tumor progression via CRISPR-engineered brain organoids.
Ishahak M, Han RH, Annamalai D, Woodiwiss T, McCornack C, Cleary RT, DeSouza PA, Qu X, Dahiya S, Kim AH, Millman JR. Ishahak M, et al. Among authors: desouza pa. bioRxiv [Preprint]. 2024 Aug 3:2024.08.02.606387. doi: 10.1101/2024.08.02.606387. bioRxiv. 2024. PMID: 39211284 Free PMC article. Preprint.
Effects of extended-release niacin with laropiprant in high-risk patients.
HPS2-THRIVE Collaborative Group; Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J. HPS2-THRIVE Collaborative Group, et al. N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955. N Engl J Med. 2014. PMID: 25014686 Free article. Clinical Trial.
56 results